Case Study: Identifying Opportunities in the Drug Registration and Reimbursement Approval Process Brief: Our client faced delays in China’s new drug registration and reimbursement approval process and wanted to reduce time-to-market for new products. Emerging Strategy’s Solution: Emerging Strategy conducted detailed interviews with our client’s regulatory affairs staff in China to learn about specific bottlenecks at various stages of the process. To gain a clear understanding of pain points and how to address them, we mapped the entire registration and reimbursement approval process, including key stakeholders. We interviewed regulators in departments. responsible for registration and reimbursement to understand their attitude to various disease areas, and to identify attitudes or policy c

Join for free to read